During the past decade, Sykehuset Innlandet HF Hamar conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sykehuset Innlandet HF Hamar" #1 sponsor was "Norwegian University of Science and Technology" with 2 trials, followed by "Bayer" with 1 trials sponsored, "Diakonhjemmet Hospital" with 1 trials sponsored, "Oslo University Hospital" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sykehuset Innlandet HF Hamar" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Ferrosan AS" with 1 trials as a collaborator, "Haukeland University Hospital" with 1 trials as a collaborator, "Helse Fonna HF" with 1 trials as a collaborator and "Helse Forde" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Sykehuset Innlandet HF Hamar" are "Anorectal Fistula" (1 trials), "Cancer Metastatic" (1 trials), "Chronic Kidney Disease" (1 trials), "Colitis" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Sykehuset Innlandet HF Hamar" in a lesser frequency.

Most popular intervention types in "Sykehuset Innlandet HF Hamar" are "Drug" (7 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ARRY-371797 (PF-07265803)" (1 trials), "Aflurax" (1 trials), "Atezolizumab" (1 trials) and "BAY2327949" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sykehuset Innlandet HF Hamar" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Sykehuset Innlandet HF Hamar". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Sykehuset Innlandet HF Hamar, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sykehuset Innlandet HF Hamar, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".